Navigation Links
Cypin Production Announces Launch of U.S./China BioPharma Conference:
Date:11/3/2010

PHILADELPHIA, Nov. 2, 2010 /PRNewswire/ -- Cypin Production, a leader in bringing together experts in biopharmaceuticals in the United States and China, is pleased to announce the already-high interest being garnered for its upcoming conference:  "U.S.-CHINA PHARMA: Innovative Strategies and Partnership Models for R&D Success".

The conference, which is scheduled for May 23-24, 2011 at the Hub Cira Centre in Philadelphia, is being chaired by Mikael Dolsten, M.D., Ph.D., President of Worldwide Research & Development (WRD) at Pfizer. A physician with more than 20 years experience in the pharmaceutical industry, Dr. Dolsten oversees thousands of world-class scientists and researchers and understands how important it is for today's U.S. bio-pharma leaders to have strong liaisons with their colleagues in China.

The conference is already off to a strong start, having garnered a renowned speaker faculty. Among the companies whose experts on best practices will be featured: Pfizer Worldwide Research & Development, Merck & Co., Novartis Vaccines & Diagnostics, Abbott Laboratories, Genzyme Transplant and Oncology, LIMR Chemical Genomics Center, the University City Science Center, Crown Bioscience, Bay City Capital, and Safeguard Scientifics, to name just a few.

Among the topics scheduled for this conference are:

  • Comparing China, China's key Asian competitors, and the United States in terms of strengths and weaknesses in pharmaceutical R&D (discovery, preclinical, chemical & formulation, and clinical)
  • Exploring emerging business models and key drivers for U.S.-China Pharma R&D partnerships
  • Important cross-cultural aspects of conducting business activities in China
  • Identifying R&D strategies to cost-effectively expand product portfolios
  • Discussing new strategies to feed R&D pipeline through academic/industry partnerships
  • Examining the role of technology transfer and licensing, and assess potential investment opportunities

Early-bird registration is already available. For fees, to register, and to keep abreast of updated information, check into this website: http://www.chinarndpartnership.com

Media: For comments/additional information on this conference, or on U.S./China biopharma in general, contact Judy Tsui (Twee). Email: judy@cypinproduction.com or phone: 917-338-7778.  


'/>"/>
SOURCE Cypin Production
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
2. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
3. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
4. Increasing Dairy Milk Production with Electrolyzed Drinking Water
5. Pew Commission Says Industrial Scale Farm Animal Production Poses Unacceptable Risks to Public Health, Environment
6. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
7. Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter
8. Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
9. DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines
10. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
11. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... astic drugs develop from traditional single antineoplastic drug towards ... at multiple links. Research and development of antineoplastic drugs ... Download the full report: https://www.reportbuyer.com/product/4696059/ ... new tumors in China every ... industrialization and lifestyles changed by factors like urbanization, malignant ...
(Date:2/22/2017)... Feb. 22, 2017 Summary Provides ... deals and agreements entered into by the worlds leading ... Description The Global Motor Neurone Disease Partnering ... access to partnering deals and agreements entered into by ... in partnering deals - Top deals by value ...
(Date:2/22/2017)... , Feb. 22, 2017  Corin Group announced ... a device used to treat patients with both a ... shoulder arthritis. The condition, known as cuff tear arthropathy, ... shoulder. The Humelock Reversed Shoulder System, ... extremities technology company based near Lyon, France ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... A cylindrical “pipeline” ... sometimes harder to reach ones, according to the results of a clinical trial ... in Houston by Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Baptist Health ...
(Date:2/22/2017)... ... ... Sideline Products participated in the World Horse Expo held in Timonium, MD ... production crew. Tom Seay’s program “Best of America by Horseback” is broadcasted on ... be featured on April 6, 2017. After the broadcast, the clip will be posted ...
(Date:2/22/2017)... ... ... Using the power of the internet, IdrisArkette.com has managed to produce more ... just 24 months, thousands of individuals interested in a medical procedure managed to be ... is not getting quieter. In fact it’s becoming noisier by the day. If you ...
(Date:2/22/2017)... ... , ... ANGLESTRONG , the new recovery management app with multiple innovative ... Store and Google Play . Florida-based Sober Network, Inc., the premier provider ... with Angle to build ANGLESTRONG. The new recovery management app is a passion project ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the ... featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... neurosurgeons in Michigan performing minimally invasive back surgery that often results in less ...
Breaking Medicine News(10 mins):